Target intelligence / Profile preview

Spliceosome (pre-mRNA splicing machinery)

Molecular classification
Ribonucleoprotein complex, RNA–protein complex, Other (not a receptor, enzyme, transporter, etc.—rather, a multi-protein RNA-processing complex)
01

Overview

The **pre-mRNA splicing machinery** (commonly called the **spliceosome**) is a large and highly dynamic ribonucleoprotein complex responsible for catalyzing the removal of introns from nuclear pre-mRNA transcripts in eukaryotic cells. The spliceosome comprises five small nuclear RNAs (snRNAs: U1, U2, U4, U5, and U6) and approximately 150–170 associated protein factors in humans. These components assemble stepwise on pre-mRNA to recognize exon–intron boundaries and catalyze two sequential transesterification reactions, excising introns and ligating exons to generate mature mRNA. The splicing machinery regulates alternative splicing, influencing gene expression and protein diversity. Disruption or modulation of spliceosome function has therapeutic relevance in diseases like cancer, where alternative splicing is frequently dysregulated[1][4][6]. Drugs that target components of the splicing machinery can alter splicing choices or induce cell death, but these interventions risk toxicity due to the essential nature of splicing in normal cells. Specific mutations in splicing factors (for example, SF3B1, U2AF1) are found in several cancers and can serve as biomarkers or drug targets. **Note:** - The CDC5 family of Myb-related proteins are required for pre-mRNA splicing and are associated with the spliceosome, based on protein–protein interactions and colocalization studies, but they are specific components and not synonymous with the entire splicing machinery[3]. - If querying specifically for "MYB pre-mRNA," this is merely the precursor transcript for the MYB gene and not in itself a therapeutic target. - The most precise molecular target based on the query is the spliceosome or splicing machinery, not "MYB pre-mRNA / Splicing Machinery" as a combined entity. To summarize: "MYB pre-mRNA / Splicing Machinery" is not a canonical, singular molecular target. "Spliceosome (pre-mRNA splicing machinery)" is the correct entity, and the query as written is **incorrect** or at least imprecise. The information above provides everything needed for structured indexing according to your schema[1][3][4][6].

Other names
pre-mRNA splicing machineryspliceosomesplicing complex
02

Mechanism of action

Inhibition of spliceosome assembly or function Modulation of alternative splicing patterns

03

Biological functions

pre-mRNA processingIntron removalAlternative splicing regulationGene expression regulation
04

Disease associations

CancerGenetic diseases (e.g., caused by splicing defects)Neurodegenerative diseasesOther
05

Safety considerations

Broad effects on mRNA processing can cause hematological toxicity, neurotoxicity, and off-target effectsEssential for normal gene expression in all cells; selective inhibition is challenging
06

Interacting drugs

Spliceostatin A

4 more in the full profile.

07

Biomarkers

Splice site mutations (for some cancers)Expression of splicing factor genes (e.g., SF3B1, U2AF1 mutations in cancer)Aberrant MYB mRNA splice variants in certain leukemias

Beyond the preview

Go deeper on Spliceosome (pre-mRNA splicing machinery).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spliceosome (pre-mRNA splicing machinery).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call